Table 1 Demographic, illness severity and treatment data
Variable | N = 110 |
|---|---|
Age, years, mean (SD) | 50.9 (16.9) |
Gender, male/female, n (%) | 70 (63.6)/40 (36.4) |
Height, m, mean (SD) | 1.71 (0.09) |
Weight, kg, mean (SD) | 80.9 (22.4) |
Body surface area, m2, mean (SD) | 1.92 (0.24) |
APACHE II, mean (SD) | 16.1 (6.20) |
Modified SOFA, median [IQR] | 3 [2-5] |
Admission type, n (%) | Â |
    - Elective | 15 (13.6) |
    - Emergency | 33 (30.0) |
    - Surgical emergency | 37 (33.6) |
    - Trauma | 25 (22.7) |
Mechanical ventilation, n (%) (n = 108) | 63 (57.3) |
Intravenous contrast administration, n (%) (n = 109) | 30 (27.3) |
Frusemide administration, n (%) | 13 (11.8) |
Mannitol administration, n (%) | 4 (3.6) |
Vasopressors, n (%) | 33 (30.0) |
Systemic inflammatory response syndrome, n (%) | 95 (86.4) |
Plasma creatinine concentration, μmol/L, mean (SD) | 68.5 (21.8) |
Plasma creatinine concentration + 24 hrs, μmol/L, mean (SD) (n = 80) | 63.0 (19.6) |
ICU length of stay, days, median [IQR] | 4 [2-10] |
ICU mortality, n (%) | 11 (10) |